Skip to main
MOH

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 17%
Hold 75%
Sell 8%
Strong Sell 0%

Bulls say

Molina Healthcare has demonstrated significant growth in its Marketplace utilization, achieving a quarterly Medical Loss Ratio (MLR) of 95.6% in 3Q25, which grew by 10.2% quarter-over-quarter. Additionally, the company reported a notable 360 basis point increase in its Medicare MLR to 93.6% during the same period, indicating improvement in profitability trends. Furthermore, there are strong upside possibilities associated with a quicker recovery in Medicaid rates and the potential for new Medicaid contracts, supporting a positive long-term outlook for the company's financial performance.

Bears say

Molina Healthcare's fourth-quarter earnings per share (EPS) fell significantly short of expectations, reported at ($2.75), which raised concerns primarily due to Medicaid retroactive items and ongoing trend pressures. The company is projected to experience year-over-year margin compression in its Medicaid segment, expected to decline to 1.2% in 2026, contrasting unfavorably with peers like UnitedHealth Group and Elevance Health that are guiding less severe declines. Additionally, the anticipated drop in Medicaid membership by 2.6% and lowered EPS estimates for 2026 and 2027 to $5.04 and $7.66, respectively, indicate increasing financial vulnerabilities related to Medicaid and Marketplace pressures.

Molina Healthcare (MOH) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 17% recommend Buy, 75% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Hold based on their latest research and market trends.

According to 12 analysts, Molina Healthcare (MOH) has a Hold consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $156.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $156.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.